ProKidney Corp to Invest $458 Million in Greensboro; Create 330 New Jobs
ProKidney Corp., a late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), will invest $458 million to build a new biomanufacturing facility in Greensboro, North Carolina, creating 330 new jobs in Guilford County. The manufacturing facility will allow the company to commercialize its cell therapy.
ProKidney uses a patented and proprietary cell therapy platform called REACT (Renal Autologous Cell Therapy) to help treat CKD by preserving the kidney function of patients with a high risk of kidney failure, by using the patient’s own kidney cells. REACT is currently undergoing phase 3 trials with a planned completion date of February 2027. The company was founded in 2018 and is headquartered in Winston-Salem. While salaries will vary by position, the average wage will be $74,636, which is higher than Guilford County’s average wage of $57,190.